ArticleMultiple sclerosis journal - experimental, translational and clinical

Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metrics.

Carrie M Hersh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.